Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type ( Autologous Therapies, Non-Stem Cell Therapies, Non-Stem Cell Therapies), By Therapeutic Area (Oncology, Dermatology), By Region, And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Therapeutic Area
  • 1.2.2. Therapy Type
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Autologous Cell Therapy Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of chronic and degenerative diseases
    • 3.2.1.2. Reduced risk of autologous cell therapy rejection
    • 3.2.1.3. Growing demand for personalized medicine
    • 3.2.1.4. Increasing investments in research & development
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of therapy and limited affordability
    • 3.2.2.2. Stringent regulatory requirements and long approval timelines
• 3.3. Autologous Cell Therapy Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. Pipeline Analysis
  • 3.3.4. COVID-19 Impact Analysis

Chapter 4. Therapy Type Business Analysis

• 4.1. Global Autologous Cell Therapy Market: Therapy Type Segment Dashboard
• 4.2. Global Autologous Cell Therapy Market: Therapy Type Movement Analysis
• 4.3. Global Autologous Cell Therapy Market Estimates and Forecasts, By Therapy Type (USD Million)
• 4.4. Stem Cell Therapies
  • 4.4.1. Stem cell therapies market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. BM, Blood, & Umbilical Cord-derived Stem Cells
    • 4.4.2.1. BM, blood, & umbilical cord-derived stem cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Adipose-Derived Cells
    • 4.4.3.1. Adipose-Derived Cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Non-stem Cell Therapies
  • 4.5.1. Non-stem cell therapies market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.2. T-Cell Therapies
    • 4.5.2.1. T-Cell Therapies market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2.2. CAR T Cell Therapy
      • 4.5.2.2.1. CAR T cell therapy market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2.3. T Cell Receptor (TCR)-based
      • 4.5.2.3.1. T Cell Receptor (TCR)-based market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Others
    • 4.5.3.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Therapeutic Area Business Analysis

• 5.1. Global Autologous Cell Therapy Market: Therapeutic Area Dashboard
• 5.2. Global Autologous Cell Therapy Market: Therapeutic Area Movement Analysis
• 5.3. Global Autologous Cell Therapy Market Estimates and Forecasts, By Therapeutic Area, Revenue (USD Million)
• 5.4. Oncology
  • 5.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Cardiovascular Diseases
  • 5.5.1. Cardiovascular diseases market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Musculoskeletal Disorders
  • 5.6.1. Musculoskeletal disorders market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Dermatology
  • 5.7.1. Dermatology market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8.2. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Regional Business Analysis

• 6.1. Regional Dashboard
• 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.3. North America
  • 6.3.1. U.S.
    • 6.3.1.1. Key country dynamics
    • 6.3.1.2. Regulatory framework
    • 6.3.1.3. Competitive scenario
    • 6.3.1.4. Target disease prevalence
    • 6.3.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.2. Canada
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. Target disease prevalence
    • 6.3.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. UK
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. Target disease prevalence
    • 6.4.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Target disease prevalence
    • 6.4.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Switzerland
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Target disease prevalence
    • 6.4.3.5. Switzerland market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Japan
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. Target disease prevalence
    • 6.5.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Target disease prevalence
    • 6.5.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. India
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Target disease prevalence
    • 6.5.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. South Korea
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Target disease prevalence
    • 6.5.4.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Rest of the World
  • 6.6.1. Rest of the world market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Key Company Position Analysis, 2024
• 7.3. Company Profiles/Listing
  • 7.3.1. Bluebird bio, Inc.
    • 7.3.1.1. Company overview
    • 7.3.1.2. Financial performance
    • 7.3.1.3. Product benchmarking
    • 7.3.1.4. Strategic initiatives
  • 7.3.2. Novartis AG.
    • 7.3.2.1. Company overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Product benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. Holostem S.R.L
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Product benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. Pharmicell Co. Inc
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Gilead Sciences, Inc. (Kite)
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Bristol Myers Squibb Company
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Johnson & Johnson (Janssen Global Services, LLC.)
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. JW Therapeutics
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Vertex Pharamaceuticals Inc.
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Autolus therapeutics
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives

List of Tables

• Table 1 List Of Secondary Sources
• Table 2 Global Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
• Table 3 Global Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
• Table 4 Global Autologous Cell Therapy Market By Region, 2018 - 2030 (USD Million)
• Table 5 North America Autologous Cell Therapy Market By Country, 2018 - 2030 (USD Million)
• Table 6 North America Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
• Table 7 North America Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
• Table 8 U.S. Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
• Table 9 U.S. Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
• Table 10 Canada Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
• Table 11 Canada Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
• Table 12 Europe Autologous Cell Therapy Market By Country, 2018 - 2030 (USD Million)
• Table 13 Europe Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
• Table 14 Europe Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
• Table 15 Germany Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
• Table 16 Germany Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
• Table 17 UK Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
• Table 18 UK Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
• Table 19 Switzerland Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
• Table 20 Switzerland Autologous Cell Therapy MarketBy Therapeutic Area, 2018 - 2030 (USD Million)
• Table 21 Asia Pacific Autologous Cell Therapy Market By Country, 2018 - 2030 (USD Million)
• Table 22 Asia Pacific Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
• Table 23 Asia Pacific Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
• Table 24 China Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
• Table 25 China Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
• Table 26 Japan Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
• Table 27 Japan Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
• Table 28 India Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
• Table 29 India Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
• Table 30 South Korea Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
• Table 31 South Korea Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
• Table 32 Rest Of The World Autologous Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
• Table 33 Rest Of The World Autologous Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Autologous Cell Therapy Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 PESTEL Analysis
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 Global Autologous Cell Therapy Market: Therapy Type Key Takeaways
• Fig. 12 Global Autologous Cell Therapy Market: Therapy Type Movement Analysis
• Fig. 13 Global Autologous Cell Therapy Market For Autologous Stem-Cell Therapies, 2018 - 2030 (USD Million)
• Fig. 14 Global Autologous Cell Therapy Market For BM, Blood, & Umbilical Cord-Derived Stem Cell Therapies, 2018 - 2030 (USD Million)
• Fig. 15 Global Autologous Cell Therapy Market For Adipose Derived Cells, 2018 - 2030 (USD Million)
• Fig. 16 Global Autologous Cell Therapy Market For Others, 2018 - 2030 (USD Million)
• Fig. 17 Global Autologous Cell Therapy Market For Autologous Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
• Fig. 18 Global Autologous Cell Therapy Market For T-Cell Therapies, 2018 - 2030 (USD Million)
• Fig. 19 Global Autologous Cell Therapy Market For CAR T Cell Therapy, 2018 - 2030 (USD Million)
• Fig. 20 Global Autologous Cell Therapy Market For T Cell Receptor (TCR)-Based, 2018 - 2030 (USD Million)
• Fig. 21 Global Autologous Cell Therapy Market For Other Autologous Non Stem-Cell Therapies, 2018 - 2030 (USD Million)
• Fig. 22 Global Autologous Cell Therapy Market: Therapeutic Area Key Takeaways
• Fig. 23 Global Autologous Cell Therapy Market: Therapeutic Area Movement Analysis
• Fig. 24 Global Autologous Cell Therapy Market For Oncology, 2018 - 2030 (USD Million)
• Fig. 25 Global Autologous Cell Therapy Market For Cardiovascular Disease (CVD), 2018 - 2030 (USD Million)
• Fig. 26 Global Autologous Cell Therapy Market For Musculoskeletal Disorders, 2018 - 2030 (USD Million)
• Fig. 27 Global Autologous Cell Therapy Market For Dermatology, 2018 - 2030 (USD Million)
• Fig. 28 Global Autologous Cell Therapy Market For Others, 2018 - 2030 (USD Million)
• Fig. 29 Regional Outlook, 2024 & 2030
• Fig. 30 North America Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
• Fig. 31 U.S.Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
• Fig. 32 Canada Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
• Fig. 33 Europe Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
• Fig. 34 Germany Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
• Fig. 35 UK Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
• Fig. 36 Switzerland Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
• Fig. 37 Asia Pacific Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
• Fig. 38 Japan Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
• Fig. 39 China Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
• Fig. 40 India Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
• Fig. 41 South Korea Autologous Cell Therapy Market, 2018 - 2030 (USD Million)
• Fig. 42 Rest Of The World Autologous Cell Therapy Market, 2018 - 2030 (USD Million)